Click on a filter below to refine your search. Remove a filter to broaden your search.
Integrated behavioral health services may help address patient needs with opioid use disorder, the authors say.
The American Medical Association applauded the approval to improve access to nonprescription naloxone as a way to curb the opioid epidemic.
The money will be used in efforts to reverse the damage of the opioid crisis.
A strong recommendation was made against long-term opioid therapy, especially for younger age groups and those with substance use disorder.
Risk factors for persistent opioid use include prior substance abuse, smoking, higher body mass index and fracture fixation surgery.
The nasal spray version of naloxone will be available at select retailers for $44.99 for a box of two doses.